Xu et al. identified a new FLT3/Hedgehog inhibitor, called Triptonide, with interesting abilities to specifically inhibit FLT3-ITDmut AML cells, sparing normal cells. This evidence concerns the gene FLT3 and acute myeloid leukemia.